NRC HEALTH

Tickers
NRC
Headquarters
Not recorded
SEC CIK
0000070487
Website
Not recorded

Closing prices

Latest close, 23.49

Closing prices for NRC249 stored closes for NRC from 3 Nov 2025 to 29 Oct 2026. Lowest 12.03 on 17 Feb 2026, highest 23.49 on 29 Oct 2026, latest 23.49 on 29 Oct 2026.Close10.0015.0020.0025.003 Nov 20251 May 202629 Oct 2026
249 stored closes, oldest first. End of day, not intraday.

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

No Drugs@FDA application has a sponsor name that matches this company.

Data provided by the U.S. Food and Drug Administration (Drugs@FDA). Sponsors are matched to companies by name; subsidiaries do not link.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

Latest value of each metric as reported to the SEC
MetricReported valuePeriodFiling
Revenue35,392,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Revenue on sec.gov (opens in a new tab)Filed
Net income (loss)−3,283,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Net income (loss) on sec.gov (opens in a new tab)Filed
Research and development expenseNot reported in XBRL filings since 2015
Operating expenses38,630,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Operating expenses on sec.gov (opens in a new tab)Filed
Cash and cash equivalents3,327,000 USD At 30 Jun 2026 FY2026 Q210-Q for Cash and cash equivalents on sec.gov (opens in a new tab)Filed
Short-term investments and marketable securitiesNot reported in XBRL filings since 2015
Total liabilities129,603,000 USD At 30 Jun 2026 FY2026 Q210-Q for Total liabilities on sec.gov (opens in a new tab)Filed
Stockholders' equity6,549,000 USD At 30 Jun 2026 FY2026 Q210-Q for Stockholders' equity on sec.gov (opens in a new tab)Filed
Common shares outstanding (cover page)22,119,566 shares At 31 Jul 2026 FY2026 Q210-Q for Common shares outstanding (cover page) on sec.gov (opens in a new tab)Filed

History

Revenue, newest period first
PeriodReported valueFiling
1 Apr 2026 to 30 Jun 2026 FY2026 Q235,392,000 USD10-Q filed 4 Aug 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2026 to 31 Mar 2026 FY2026 Q134,803,000 USD10-Q filed 6 May 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2025 to 31 Dec 2025 FY2025137,390,000 USD10-K filed 5 Mar 2026 on sec.gov (opens in a new tab)Filed
1 Jul 2025 to 30 Sep 2025 FY2025 Q334,608,000 USD10-Q filed 7 Nov 2025 on sec.gov (opens in a new tab)Filed
1 Apr 2025 to 30 Jun 2025 FY2026 Q234,038,000 USD10-Q filed 4 Aug 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2025 to 31 Mar 2025 FY2026 Q133,551,000 USD10-Q filed 6 May 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2024 to 31 Dec 2024 FY2025143,060,000 USD10-K filed 5 Mar 2026 on sec.gov (opens in a new tab)Filed
1 Jul 2024 to 30 Sep 2024 FY2025 Q335,819,000 USD10-Q filed 7 Nov 2025 on sec.gov (opens in a new tab)Filed

The newest 12 periods of each metric are listed; older ones are on sec.gov.

Values as reported in the company's XBRL filings to the SEC, one per calendar period (SEC frames); not adjusted, not audited by HealthTrade, and not investment advice.

Source: SEC XBRL company facts (opens in a new tab) · Licence: public-domain · as of 2026-10-25 · read

SEC filings

SEC filings from NRC HEALTH, newest first
FormFiledWhat it coversDocument
8-K Current report (8-K) View Current report (8-K) filed 27 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001437749-26-033639 (opens in a new tab)
8-KEvent 14 Oct 2026 Current report (8-K)
  • Departure or appointment of directors or officers (Item 5.02)
View Current report (8-K) filed 19 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001437749-26-032899 (opens in a new tab)
8-KEvent 7 Aug 2026 Current report (8-K)
  • Departure or appointment of directors or officers (Item 5.02)
View Current report (8-K) filed 11 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001437749-26-027031 (opens in a new tab)
10-QEvent 30 Jun 2026 Quarterly report (10-Q) View Quarterly report (10-Q) filed 4 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001437749-26-025624 (opens in a new tab)
8-K Current report (8-K)
  • Results of operations and financial condition (Item 2.02)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 28 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0001437749-26-024663 (opens in a new tab)
8-KEvent 23 Jun 2026 Current report (8-K)
  • Amendments to articles or bylaws; change in fiscal year (Item 5.03)
  • Shareholder vote results (Item 5.07)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 29 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001437749-26-021938 (opens in a new tab)
4Event 23 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 25 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001008886-26-000189 (opens in a new tab)
4Event 23 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 25 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001008886-26-000188 (opens in a new tab)
4Event 23 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 25 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001008886-26-000187 (opens in a new tab)
4Event 23 Jun 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 25 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001008886-26-000186 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
None in this period
Sells code S
None in this period
Other all other codes
None in this period

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.